Treatment with CFTR modulators and subsequent remission of AA amyloidosis

2026 KDIGO Anemia Management Guidelines — NephJC

A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy

Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial | NEJM

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinica...

Empagliflozin, the kidney, and what we still don’t understand — NephJC

Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension | NEJM

Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study

Loop Diuretic Dose Intensification versus Adjuvant Thiazide ... : Journal of the American Society of Nephrology

Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer | NEJM

GLP-1RA Semaglutide Delays the Progression of ADPKD Through Regulation of Glycolysis, Mitochondria Function and Ketosis - PubMed

Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors - PubMed